Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 177 (3), 256-63

Bimodal Effects of MK-801 on Locomotion and Stereotypy in C57BL/6 Mice

Affiliations

Bimodal Effects of MK-801 on Locomotion and Stereotypy in C57BL/6 Mice

Jinhua Wu et al. Psychopharmacology (Berl).

Abstract

Rationale: Systemic injection of the non-competitive NMDA (N-methyl-D-aspartate) receptor antagonist MK-801 (dizocilpine maleate) causes both increased locomotion in rodents and various stereotypic behaviors that are proposed to model certain aspects of schizophrenic symptoms in humans.

Objectives: This study presents a comprehensive characterization of the bimodal effects of MK-801 on locomotion and stereotypy in the C57BL/6 mouse strain, a strain commonly used for genetically modified mice.

Results: We found that it is important to analyze both locomotion and stereotypy in parallel, as MK-801-induced stereotypy results in abnormal movements that are recorded as locomotion by automated beam detection systems. Furthermore, it is important to analyze the bimodal effects of MK-801 over an extended time span, rather than the commonly used narrower time window, as at higher doses (e.g., above 0.3 mg/kg) the hyperlocomotion phase develops only after the stereotypic phase subsides. We also observed that the apparent dose-response curve is very sensitive to the particular time window chosen for analysis because MK-801 affects both the time course and maximum value of stimulated locomotion. We show that analyzing the absolute peak value of locomotion induced for each animal, rather than group-averaged time courses, provides a measure that is sensitive over a wider range of MK-801 doses. Interestingly, MK-801 even at a very low dose of 0.02 mg/kg suppressed rather than enhanced rearing behavior, differing in this regard from amphetamine.

Conclusions: The non-competitive NMDA receptor antagonist MK-801 induces a complex pattern of behavioral modification in mice with respect to both the time course and the dose-response relationship of behavioral changes. The results of this study provide a foundation and frame of reference for the growing interest in studying MK-801-induced behavior in mice.

Similar articles

See all similar articles

Cited by 19 PubMed Central articles

See all "Cited by" articles

References

    1. Clin Neuropharmacol. 1997 Oct;20(5):375-84 - PubMed
    1. Neuropsychopharmacology. 1992 May;6(3):145-53 - PubMed
    1. Psychopharmacology (Berl). 2001 Mar 1;154(2):177-88 - PubMed
    1. Pharmacol Biochem Behav. 1997 Feb;56(2):311-6 - PubMed
    1. Psychopharmacology (Berl). 1985;85(1):57-61 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

Feedback